Idorsia Aktie 36346343 / CH0363463438
3.20
CHF
-0.01
CHF
-0.19%
17:30:20
SWX
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen | |||||
Ausblick |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 58.65 |
Clozel Family | 25.86 |
Idorsia Ltd. | 5.32 |
Johnson & Johnson | 5.10 |
Rudolf Maag | 4.79 |
Lazard Asset Management Ltd. | 2.83 |
Fidelity Management & Research Co. LLC | 2.82 |
American Funds Small Cap World Fund | 2.30 |
Government Pension Fund - Global (The) | 1.68 |
American Funds New Economy Fund | 1.58 |
Longleaf Partners Small Cap Fund | 1.17 |
Vanguard Total International Stock Index Fund | 0.87 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. EUR) - Aktiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 941 | 775 | 1'035 | 1'077 | 596 |
Summe Anlagevermögen | 1'249 | 816 | 1'223 | 1'268 | 566 |
Summe Aktiva | 1'407 | 1'004 | 1'435 | 1'483 | 904 |
Bilanz (in Mio. EUR) - Passiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 584 | 643 | 638 | 1'163 | 1'227 |
Summe Fremdkapital | 749 | 840 | 850 | 1'379 | 1'565 |
Summe Eigenkapital | 658 | 164 | 585 | 104 | -661 |
Summe Passiva | 1'407 | 1'004 | 1'435 | 1'483 | 904 |
Adresse
Hegenheimermattweg 91, 4123 Allschwil | |
Telefon | +41 (58) 844-00-00 |
URL | http://www.idorsia.com |
Management
Alberto Gimona
Head-Global Clinical Development & Executive VP |
Alexander Khatuntsev
Senior VP & Head-Global Human Resources |
Andrew C. Weiss
SVP, Head-Corporate Communication & IR |
André C. Muller
Chief Financial Officer & Executive Vice President |
Felix R. Ehrat
Non-Executive Director |
Guy Braunstein
Chief Medical Officer & Executive Vice President |
Jean-Paul Clozel
Chief Executive Officer & Director |
Julien Gander
Senior Vice President & Group General Counsel |
Jörn Aldag
Non-Executive Director |
Martine Clozel
Chief Scientific Officer & Executive VP |
Mathieu Simon
Chairman |
Peter N. Kellogg
Non-Executive Director |
Sandesh Mahatme
Non-Executive Director |
Simon Jose
Chief Commercial Officer & Executive VP |
Srishti Gupta
Non-Executive Director |